HDAC9 and ovarian carcinoma: The HDAC inhibitor M344, which is specific for HDAC6 and to a lesser extent HDAC1, has been shown to promote growth inhibition, cell cycle arrest, and apoptosis, as well as inhibit BRCA1 expression in ovarian cancer cell lines (119, 120).